Detection of extended spectrum β-lactamases in the routine clinical microbiology laboratory
- 1 January 2002
- journal article
- Published by Elsevier BV in Pathology
- Vol. 34 (4), 362-364
- https://doi.org/10.1080/003130202760120544
Abstract
To compare three methods of confirming the presence of an extended spectrum β-lactamase (ESBL) enzyme with the initial detection (i.e., screening) by the Vitek AMS. Gram-negative bacteria which flagged as ESBL-positive in the Vitek GNS card, or were suspected of harbouring an enzyme, were further tested by each of the following methods: (a) combination disc test using cefpodoxime, ceftazidime and cefotaxime with and without clavulanate; (b) cefotaxime ESBL Etest; and (c) Jarlier keyhole method with cefpodoxime (10 μg), cefotaxime (5 μ) and aztreonam (30 μg) placed 15 mm away from an augmentin (30 μg) disc. A total of 52 isolates were investigated, representing an 18-month time period. Fifty of these were positive by Vitek. Twenty-eight (56%) were confirmed by other methods (true positives). Of the 44% Vitek-positive/confirmatory test-negative (false positives), eight were Escherichia coli which was 53% of all E. coli tested. The majority of other false-positive isolates were Klebsiella oxytoca (24% overall) which were all Vitek- and Etest-positive but negative by the combination disc test. All ESBL-positive strains by Vitek should be confirmed by the combination disc test using all three antibiotics. This will enable differentiation of ‘true’ ESBLs from false-positive organisms, including K1 hyperbetalacta-mase-producing Klebsiella oxytoca and AmpC-producing organisms. The cefpodoxime combination discs gave the best differentiation in this study with only one ESBL organism being missed.Keywords
This publication has 8 references indexed in Scilit:
- Outcome of Cephalosporin Treatment for Serious Infections Due to Apparently Susceptible Organisms Producing Extended-Spectrum β-Lactamases: Implications for the Clinical Microbiology LaboratoryJournal of Clinical Microbiology, 2001
- Characterization of Extended-Spectrum β-Lactamase (TEM-52)-Producing Strains of Salmonella enterica Serovar Typhimurium with Diverse Resistance PhenotypesJournal of Clinical Microbiology, 2001
- Outbreak of Nosocomial Infections Due to Extended-Spectrum β-Lactamase-Producing Strains of Enteric Group 137, a New Member of the Family Enterobacteriaceae Closely Related to Citrobacter farmeri and Citrobacter amalonaticusJournal of Clinical Microbiology, 2000
- Detection of Extended-Spectrum β-Lactamases in Klebsiellae with the Oxoid Combination Disk MethodJournal of Clinical Microbiology, 2000
- Detection and Reporting of Organisms Producing Extended-Spectrum β-Lactamases: Survey of Laboratories in ConnecticutJournal of Clinical Microbiology, 1999
- Bases of variation in resistance to beta-lactams in Klebsiella oxytoca isolates hyperproducing K1 beta-lactamaseJournal of Antimicrobial Chemotherapy, 1997
- A functional classification scheme for beta-lactamases and its correlation with molecular structureAntimicrobial Agents and Chemotherapy, 1995
- Extended Broad-Spectrum -Lactamases Conferring Transferable Resistance to Newer -Lactam Agents in Enterobacteriaceae: Hospital Prevalence and Susceptibility PatternsClinical Infectious Diseases, 1988